Contractor that ruined 15M doses of J&J vaccine hiked price of another by 800%

Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson's COVID-19 vaccine, in Baltimore, Maryland, on April 9, 2021. (credit: Getty | Saul Loeb)

Things are not looking good for Emergent BioSolutions, the contract manufacturer that ruined 15 million doses of Johnson & Johnson's one-shot COVID-19 vaccine and millions more doses of AstraZeneca's COVID-19 vaccine at its production facility in Baltimore.

The Food and Drug Administration on Wednesday released a searing inspection report of the facility, finding a slew of significant violations and failings.

Meanwhile, federal lawmakers have opened a multi-pronged investigation into whether Emergent used ties to the Trump administration to get billions of dollars in federal contracts despite a history of failing to complete contracts. The investigation is also looking into inadequate staff training, persistent quality-control issues, and the company's unjustified" 800% price increase for an anthrax vaccine.

Read 15 remaining paragraphs | Comments